Literature DB >> 25802470

Does Visceral Fat Estimated by Dual-Energy X-ray Absorptiometry Independently Predict Cardiometabolic Risks in Adults?

Hiroyuki Sasai1, Robert J Brychta1, Rachel P Wood1, Megan P Rothney2, Xiongce Zhao1, Monica C Skarulis1, Kong Y Chen3.   

Abstract

BACKGROUND: Abdominal visceral fat, typically measured by computer tomography (CT) or magnetic resonance imaging (MRI), has been shown to correlate with cardiometabolic risks. The purpose of this study was to examine whether a newly developed and validated visceral fat measurement from dual-energy X-ray absorptiometry (DXA) provides added predictive value to the cross-sectional differences of cardiometabolic parameters beyond the traditional anthropometric and DXA adiposity parameters.
METHOD: A heterogeneous cohort of 194 adults (81 males and 113 females) with a BMI of 19 to 54 kg/m(2) participated in this cross-sectional study. Body composition was measured with a DXA densitometer. Visceral fat was then computed with a proprietary algorithm. Insulin sensitivity index (SI, measured by intravenous glucose tolerance test), blood pressures, and lipid profiles, and peak oxygen uptake were also measured as cardiometabolic risk parameters.
RESULTS: DXA-estimated visceral fat mass was associated with HDL cholesterol (regression coefficient [β] = -5.15, P < .01, adjusted R(2) = .21), triglyceride (β = 26.01, P < .01, adjusted R(2) = .14), and peak oxygen uptake (β = -3.15, P < .01, adjusted R(2) = .57) after adjusting for age, gender, and ethnicity. A subanalysis stratifying gender-specific BMI tertiles showed visceral fat, together with ethnicity, was independently associated with SI in overweight men and moderately obese women (second tertile).
CONCLUSIONS: Without requiring additional CT or MRI-based measurements, visceral fat detected by DXA might offer certain advantages over the traditional DXA adiposity parameters as means of assessing cardiometabolic risks.
© 2015 Diabetes Technology Society.

Entities:  

Keywords:  cardiometabolic risks; dual-energy X-ray absorptiometry; insulin sensitivity; visceral fat

Mesh:

Substances:

Year:  2015        PMID: 25802470      PMCID: PMC4525640          DOI: 10.1177/1932296815577424

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  37 in total

1.  Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.

Authors:  G Paradisi; L Smith; C Burtner; R Leaming; W T Garvey; G Hook; A Johnson; J Cronin; H O Steinberg; A D Baron
Journal:  Diabetes Care       Date:  1999-08       Impact factor: 19.112

2.  Precision of a new tool to measure visceral adipose tissue (VAT) using dual-energy X-Ray absorptiometry (DXA).

Authors:  Megan P Rothney; Yi Xia; Wynn K Wacker; Francois-Pierre Martin; Maurice Beaumont; Serge Rezzi; Vittorio Giusti; David L Ergun
Journal:  Obesity (Silver Spring)       Date:  2013-01       Impact factor: 5.002

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry.

Authors:  Anna M I Gradmark; Anders Rydh; Frida Renström; Emanuella De Lucia-Rolfe; Alison Sleigh; Peter Nordström; Soren Brage; Paul W Franks
Journal:  Br J Nutr       Date:  2010-04-07       Impact factor: 3.718

5.  Reductions in visceral fat during weight loss and walking are associated with improvements in VO(2 max).

Authors:  N A Lynch; B J Nicklas; D M Berman; K E Dennis; A P Goldberg
Journal:  J Appl Physiol (1985)       Date:  2001-01

6.  Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women.

Authors:  E G Kamel; G McNeill; M C Van Wijk
Journal:  Obes Res       Date:  2000-01

7.  Visceral adiposity and the prevalence of hypertension in Japanese Americans.

Authors:  Tomoshige Hayashi; Edward J Boyko; Donna L Leonetti; Marguerite J McNeely; Laura Newell-Morris; Steven E Kahn; Wilfred Y Fujimoto
Journal:  Circulation       Date:  2003-09-15       Impact factor: 29.690

8.  Dual-energy X-ray absorptiometry for quantification of visceral fat.

Authors:  Sanjiv Kaul; Megan P Rothney; Dawn M Peters; Wynn K Wacker; Cynthia E Davis; Michael D Shapiro; David L Ergun
Journal:  Obesity (Silver Spring)       Date:  2012-01-26       Impact factor: 5.002

9.  Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat.

Authors:  Lisa K Micklesfield; Julia H Goedecke; Mark Punyanitya; Kevin E Wilson; Thomas L Kelly
Journal:  Obesity (Silver Spring)       Date:  2012-01-12       Impact factor: 5.002

10.  Android fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly people.

Authors:  Seon Mee Kang; Ji Won Yoon; Hwa Young Ahn; So Yeon Kim; Kyoung Ho Lee; Hayley Shin; Sung Hee Choi; Kyong Soo Park; Hak Chul Jang; Soo Lim
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

View more
  21 in total

1.  Central obesity and risks of cardiovascular events and mortality in prevalent hemodialysis patients.

Authors:  Heba Wahid El Said; Osama Mahmoud Mohamed; Tamer Wahid El Said; Ahmed Bahaa El Serwi
Journal:  Int Urol Nephrol       Date:  2017-03-17       Impact factor: 2.370

2.  Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trial.

Authors:  Andrew P Demidowich; Anna Wolska; Sierra R Wilson; Jordan A Levine; Alexander V Sorokin; Sheila M Brady; Alan T Remaley; Jack A Yanovski
Journal:  J Clin Lipidol       Date:  2019-10-22       Impact factor: 4.766

3.  Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?

Authors:  A B Moraes; E M R Cavalari; M P de Paula; M Arruda; D S C Curi; R A Leitão; L M C de Mendonça; M L F Farias; M Madeira; L Vieira Neto
Journal:  J Endocrinol Invest       Date:  2018-11-21       Impact factor: 4.256

4.  Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.

Authors:  U Durmus; C Duran; S Ecirli
Journal:  J Endocrinol Invest       Date:  2016-11-12       Impact factor: 4.256

5.  Precision of the Hologic DXA in the Assessment of Visceral Adipose Tissue.

Authors:  Elijah K Goldberg; Ellen B Fung
Journal:  J Clin Densitom       Date:  2019-03-20       Impact factor: 2.617

6.  Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial.

Authors:  Andrew P Demidowich; Jordan A Levine; Ginikanwa I Onyekaba; Shahzaib M Khan; Kong Y Chen; Sheila M Brady; Miranda M Broadney; Jack A Yanovski
Journal:  Diabetes Obes Metab       Date:  2019-04-02       Impact factor: 6.577

7.  Assessing truncal obesity in predicting cardiometabolic risk in children: clinical measures versus dual-energy X-ray absorptiometry.

Authors:  Vincent J Palmieri; Melissa H Henshaw; Janet Carter; Shahryar M Chowdhury
Journal:  Acta Paediatr       Date:  2017-12-22       Impact factor: 2.299

Review 8.  Insulin and cancer: a tangled web.

Authors:  Brooks P Leitner; Stephan Siebel; Ngozi D Akingbesote; Xinyi Zhang; Rachel J Perry
Journal:  Biochem J       Date:  2022-03-18       Impact factor: 3.766

9.  The Effects of Hyperhydrating Supplements Containing Creatine and Glucose on Plasma Lipids and Insulin Sensitivity in Endurance-Trained Athletes.

Authors:  Thelma P Polyviou; Yannis P Pitsiladis; Carlos Celis-Morales; Benjamin Brown; John R Speakman; Dalia Malkova
Journal:  J Amino Acids       Date:  2015-06-17

10.  Precise Prediction of Total Body Lean and Fat Mass From Anthropometric and Demographic Data: Development and Validation of Neural Network Models.

Authors:  Simon Lebech Cichosz; Nicklas Højgaard Rasmussen; Peter Vestergaard; Ole Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2020-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.